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MULTIMODALrry MANAGEMENf OF 

SOFr TISSUE SARCOMAS 

INTRODUCTION 
Soft tissue sarcomas are a heterogeneous 
group of malignant tumours arising from 
connective tissues of mesenchymal origin. 
By definition sarcomas arising from bone 
or cartilage are excluded though they 
have much in common in their behaviour 
as well as in the approach to their 
management In this review of our local 
experience mesotheliomas are also 
excluded. 
The incidence of these tumours has 
considerable geographic vanatIons. 
Hawaii has the highest incidence (6.2 per 
lOO,cro). The incidence in the u.K. is 
0.5 to 0.8 per lOO,cro and in the U.S. 2 per 
lOO,cro. Over the last 34 months 24 new 
cases have been diagnosed and notified in 
the Maltese Islands. This gives an 
incidence of 2.27. 
MATERIALS AND METIIODS 
A retrospective study of all cases of soft 
tissue sarcomas diagnosed and notified in 
the Maltese Islands over the period 1.1.87 
to 31.10.89 was carried out Information 
was obtained from the cancer registry, the 
patient's hospital ftIcs and radiographic 
records. When there was reasonable doubt 
about the diagnosis a review of 
histological material submitted was 
carried out 
RESULTS 
24 new cases of soft tissue sarcoma were 
diagnosed in the period 1.1.87 to 31.10.89 
Stephen Brincat 
(34 months). There were 14 males and 10 
females with four sarcomas arising from 
the uterus, and two arising from breast. 
There were four children (less than 14 
years of age) and two adolescents. Nine 
patients received surgery alone as their 
initial treatment. Of these, three patients 
died in the immediate post operative 
period, onc developed distant meta.<;tasis 
at ftfteen months, one developed local 
recurrence, onc is alive and free of disease 
at eighteen months and the other three are 
lost to follow up. 
Another three patients had surgery limited 
to biopsy only because of inoperability of 
the tumour. All these patient'> are now 
dead (survival = 1,4,6 months) from 
disseminated disease. 
Eight patients received a combination of 
surgery and radiotherapy as primary 
treatment Five are alive and free of 
disease, one still has not completed 
treatment, onc is alive and with distant 
metastasis and one is lost to follow up. 
Two patients received surgery and 
chemotherapy and are both alive and free 
of disease. Another two patients received 
surgery, chemotherapy and radiotherapy 
as their primary treatment. Of these one 
died of disease at four months and the 
other is alive and free of disease at two 
years. 
The younger patients did considerably 
better with all four children being presently 
alive and free of disease. Three of these 
children received part of their treatment 
in the UK. Onc adolescent clied with 
extensive local disease all treatment 
having been refused. The other adolescent 
remains alive and (Tee of disease. 
Of eight patients over the age of sixty 
years, six are dea.d, one alive with disease 
and one alive and free of clisease. The 
thirteen patients still alive have had a 
median follow up of seventeen months, 
four case,.<; have been lost to follow up and 
seven patients are dead. 
Table 1 lists all our patients giving 
histology, site or primary, treatment 
received and result of follow up. 
DISCUSSION 
In comparing incidenccs of soft tissue 
sarcomas from different regions confusion 
arises because of uncertainty over which 
cases to include and which to exclude. 
For example soft tissue sarcomas arising 
from viscera are often excluded so that 
leiomyosarcomas of the uterus or 
bowel would not be included. 
Rhabdomyosarcoma arising from bladder, 
uterus or vagina however is usually 
included. Likewise some would include 
mesothelioma but most would not Using 
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TABLE I 
HISTOLOGY 
Leiomyosa 
Leiomyosa 
Leiomyosa 
Rhabdomyosa 
Liposa 
Alveolar Sa 
Angiosa 
M.F.H. 
M.FH 
C.C .Sa. 
Neurofib Sa 
Myxosa 
Cystosa 
Pleom.Sa 
Fibro.Sa 
Rhabdomyosa 
Rhabdomyosa 
M.FH 
Stromal Sa 
D.F.P. 
Fibro.Sa 
Leiomyosa 
Leiomyosa 
Rhabdomyosa 
M.FH 
C.C.Sa. 
D.F.P. 

AM.T. 

Hyst 

S 
Ch 
RT 
SITE AGE SEX 
Ileum 72 M 
Uterus 80 F 
Liver 62 M 
Abdo 56 M 
Thigh 70 M 
Thigh 17 F 
Pelvis 65 F 
Head 3 M 
Elbow 51 M 
Kidney 6 mth M 
Colon 47 M 
Abdo 79 M 
Breast 43 F 
Pelvis 17 F 
Thigh 56 M 
Chest 4 M 
Leg 30 M 
Chest 50 M 
Uterus 76 F 
Shoulder 44 M 
Breast 44 F 
Uterus 32 F 
Uterus 62 F 
Bladder 7 F 
Malignant Fibrous Histiocytoma 
Clear Cell Sarooma 
Dermatofibrosarcoma Protuberans 
Autologous Marrow Transplant 
Hysterectomy 
Surgery 
Chemotherapy 
Radiotherapy 
these criteria that is excluding viscerdl 
leiomyosarcomas our incidence would 
fall to 1.7 per lOO,(Xn 
Becausc of the rarity of these tumours 
few centres have gained much experience 
in their management. Most important 
studies on the subject have been the result 
of mul ti centre trials. 
The prognosis of the various soft tissue 
sarcomas varies somewhat from one 
histological variety to another, as does 
the natural history. By and large however 
the grade and size of the primary tumour 
is more important in determining 
prognosis and treatment than the 
1 ST TREATMENT 
Surgery 
Pall.RT 
Surgery 
Chemo 
Surg + RT 
Surg + RT 
S+ Ch + RT 
Surgery 
Surgery 
Surg + Ch 
Surgery 
Pt. Excision 
Mastectomy 
Surgery 
Surgery 
S+Ch+AMT 
Surg + RT 
Surgery 
Hyst + RT 
Surg + RT 
Mastectomy 
Hyst + RT 
Hyst + RT 
Ch + S + RT 
FOLLOW UP 
Died 4 wks post op 
Died 4 rnths post biopsy 
Died 1 wk post op 
Died 6 mths post biopsy 
FOD 6 mths 
FOD 9 mths 
Died 4 mths post op 
FOD 18 mths 
Immediate post op 
FOD 14 mths post op 
Liver mets at 15 mths 
Died 1 wk post op 
FOD 11 mths 
Died 1 mth 
Lost to follow up 
FOD 2 yrs 
FOD 18 mths 
Recur x 2 after Surg 
Lost to Follow up 
FOD 2 yrs 
Lost to Follow up 
FOD 2 yrs 
Alive wtth lung mets 
FOD 2 yrs 
histological variety of sarcoma. 
Embryonal rhabdomyosarcoma is the 
exception and the behaviour and treatment 
of this tumour is closer to that of other 
paediatric solid tumours than to that of 
the other soft tissue sarcomas. 
The brief discussion on management that 
follows refers to non- visceral soft tissue 
sarcoma and is confined to general 
principles. Soft tissue sarcomas usually 
spread by local extension along tissue 
planes often far from palpable tumour. 
The development of local recurrence 
following primary treatment doubles the 
probability that the patient will die of the 
sarcoma. 
Following simple excIsIon recurrence 
rates are of the order of 70 to 90% (fable 
2). Radical surgery is associated with 
much lower local recurrence rates, but 
often necessitates amputation of a limb or 
other mutilating surgery. For surgery to 
be radical the tumour which is not 
visualized at operation must be removed 
en bloc with a 2/3 centimetre margin in all 
directions. The results of Simon et al (1) 
provide an excellent review of what can 
be attained by radical surgery. 
Their local recurrence rate for all patients 
was 20%. Tumours in mcessible sites 
such as pelvis, buttock, groin or shoulder 
girdle recur more than those in extremities. 
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Increasing size is also associated with 
increasing risk of recurrence. 
The work of Suit and Russell (2) (fable 
3) has clearly shown that equally good 
local control of the primary tumour can 
be achieved by a combination of simple 
excision and radiotherapy. 
The two groups, surgery alone vs. surgery 
plus radiotherapy in our series are not 
-
comparable. The numbers for comparable 
cases are too small for meaningful 
analysis. 
Radiotherapy can be given pre or post­
operatively with advantages and 
disadvantages for both techniques. If 
radiation is given pre-Dperatively (3) the 
volume to be radiated is smaller, 
inoperable tumours can become operable 
and the tumour is more clearly outlined at 
operation. The risk of dissemination at 
operation is also reduced and treatment 
starts immediately removing the worrying 
risk of tumour regrowth post-Dperatively 
especially if wound healing is delayed 
while waiting to start radiotherapy. The 
main disadvantage is that there may be a 
delay in wound healing. 
When a small lesion is excised and on 
histological examination turns out to be a 
sarcoma radiotherapy can only be given 
post- operatively. Treatment volumes 
post-Dperatively must include all areas of 
possible contamination and are necessary 
larger. In our series all patients receiving 
radiotherapy did so post- operatively. 
Chemotherapy is used to reduce the size 
of large tumours thereby facilitating 
subsequent surgery. It is also used 
palliatively in the treatment of metastatic 
disease or of fungating inoperable 
primaries. Its role in adjuvant treatment 
is still uncertain but ongoing trials are 
being carried out in an attempt to identify 
a drug regimen that may improve results. 
To date one of the more effective ways of 
delivering chemotherapy in the treatment 
of sarcomas arising in an extremity has 
been by intra-arterial perfusion. 
Because of the complex interaction 
between the different modalities of 
treatment available in the management of 
soft tissue sarcomas a planned combined 
approach between surgeons and 
radiotherapists/oncologists is essential. 
It is also very useful for the clinicians to 
fully discuss these complex cases with 
their colleagues in pathology and 
diagnostic radiology. Both surgery and 
radiotherapy have to be meticulously 
planned and executed to obtain optimal 
results. 
We now have the facilities to treat the 
large majority of cases of soft tissue 
sarcoma adequately in Malta. We will 
continue to refer most of our children to 
the U.K. when intensive chemotherapy or 
highly complex surgery is needed. The 
chemotherapy programme in these cases 
which often goes on for several months 
can usually be continued in Malta. 
Likewise any radiotherapy needed could 
TABLE n 
Results of Surgery Alone. 
also be delivered in Malta with few 
exceptions. 
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Sirnon et al. definition of local reaJrrence rates: 
0/0 
100 following 
80-100 following 
50 following 
10-20 following 
5 following 
- - _. -- ­ ----~ 
incisional biopsy 
excisional biopsy 
wide excision 
radical resection 
amputation 
TABLE ill 
Results of post-operative radiation 
1} M.D. Anderson 
80% local control wtth 
80% good functional result. 
2} Massachusetts General Hospttal 
92% local control at 2 years 
84% local control at 5 years 
3} Distal lesions 
1 00% control (46/46) 
Proximal sttes (upper arm, thigh) 
36% control. 
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